前收市價 | 110.59 |
開市 | 111.10 |
買盤 | 106.40 x 100 |
賣出價 | 106.90 x 100 |
今日波幅 | 105.95 - 112.00 |
52 週波幅 | 62.55 - 163.24 |
成交量 | |
平均成交量 | 4,413,549 |
市值 | 40.8B |
Beta 值 (5 年,每月) | 1.60 |
市盈率 (最近 12 個月) | 無 |
每股盈利 (最近 12 個月) | -12.33 |
業績公佈日 | 2024年5月02日 - 2024年5月06日 |
遠期股息及收益率 | 無 (無) |
除息日 | 無 |
1 年預測目標價 | 121.94 |
Moderna (MRNA) posts data on three experimental vaccines and intends to advance them to late-stage studies. It also secures $750 million in funding from Blackstone to advance its influenza program.
Apellis Pharmaceuticals (APLS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Praxis Precision Medicines, Inc. (PRAX) and Viking Therapeutics, Inc. (VKTX) gain from positive study updates.